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Introduction
The development of safe and efficient vectors for the delivery
of genetic material into cells is one of the main hurdles for the
progress of gene therapy as a cure for several diseases, such as
cystic fibrosis and cancer.[1–4] Although viral vectors can be em-
ployed for intracellular delivery of genetic material with high
efficiency, these vectors are associated with inherent cytotoxici-
ty, immunogenicity, and mutagenicity problems as well as
having limitations in terms of the size and quantity of the in-
serted genetic materials.[5] Therefore, nonviral vectors are
emerging as an attractive alternative,[6,7] because of their ease
of production, stability, low immunogenicity and toxicity, and
capacity to deliver larger genetic payloads.[8] Among them, cat-
ionic polymers, such as polyethylenimine (PEI), poly-l-Lysine,
and poly(amido amine)s dendrimers,[9–12] have been reported
as promising materials, as these cationic polymers are able to
complex with DNA to nanosized particles (polyplexes), thereby
protecting DNA from nucleases and promoting cellular uptake
by (mainly) endocytosis.[13]
Nevertheless, these cationic polymers are not able to over-
come all the different barriers for the successful delivery of ge-
netic material inside cells, such as efficient selective cellular
uptake and endosomal escape of polyplexes, vector unpacking
and cytoplasmic trafficking, and nuclear internalization of free
DNA.[14, 15] Especially unpacking of the genetic material from
the polymer and the cellular trafficking of DNA were revealed
to be the most limiting factors for successful gene transfer in
vitro,[16] besides the obvious requirement that the cytotoxicity
of the applied polymers should be low. The latter point has
been addressed by using biodegradable polymers, possessing
hydrolytically cleavable ester groups or bioreducible disulfide
linkages in their backbone.[17–20] Moreover, the cleavage of
these groups in the cellular interior could beneficially contrib-
ute to the release of the genetic payload, leading to the devel-
opment of polymeric vectors which display similar or higher
transfection efficiency but lower cytotoxicity than their nonde-
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To evaluate the effect of quaternary nicotinamide pendant
groups on gene delivery properties, a series of poly(amido amine)
(co)polymers were synthesized by Michael addition polymeri-
zation of N, N’-cystaminebisacrylamide with variable ratios of 1-
(4-aminobutyl)-3-carbamoylpyridinium (Nic-BuNH2), and tert-
butyl-4-aminobutyl carbamate (BocNH-BuNH2), yielding poly(ami-
do amine)s (NicX-NHBoc) with X=0, 10, 30, and 50% of quater-
nary nicotinamide groups in the polymer side chains. Deprotec-
tion of the pendant Boc-NH groups afforded an analogous series
of polymers (NicX-NH2) with higher charge density (due to the
presence of protonated primary amino groups in the side chains)
and subsequent acetylation yielded a series of polymers (NicX-
NHAc) of lower hydrophobicity than the Boc-protected polymers.
The polymers with the Boc-protected or the acetylated amino
groups showed high buffer capacity in the range pH 5.1–7.4,
which is a property that can contribute to endosomal escape of
polyplexes. The presence of quaternary nicotinamide groups has
distinct beneficial effects on the gene vector properties of these
polymers. The polymers containing 30% of quaternary nicoti-
namide groups in their side chains condense DNA into small,
nanosized particles (200 nm) with positive surface charge (+
15 mV). Fluorescence experiments using ethidium bromide as a
competitor showed that the quaternary nicotinamide groups in-
tercalate with DNA, contributing to a more intimate polymer–
DNA binding and shielding. Polyplexes of nicotinamide-function-
alized poly(amido amine)s NicX-NHBoc and NicX-NHAc, formed
at 12/1 polymerDNA mass ratio, efficiently transfect COS-7 cells
with efficacies up to four times higher than that of PEI (Exgen
500), and with essentially absence of cytotoxicity. NicX-NH2 poly-
mers, possessing protonated primary amino groups in their side
chains, have a higher cytotoxicity profile under these conditions,
but at lower 3/1 polymer-DNA mass ratio also these polymers
are capable of efficient transfection, while retaining full cell via-
bility.
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gradable counterparts. However, it is conceivable that for effi-
cient transfection also the degree of protection and the stage
at which DNA is released from its protective polymeric envi-
ronment is critical, as insufficient protection and/or early re-
lease can lead to degradation of most of the internalized DNA
because of the presence of DNAses in the cytoplasm.
Previous studies of Ferruti et al.[21,22] have shown that poly(a-
mido amine)s are a versatile class of polymers that have prom-
ising properties for gene and drug delivery as these peptido-
mimetic polymers are biodegradable and many of them show
essentially no or only low cytotoxicity. Recently, we have found
that the presence of disulfide linkages in the main chain of the
poly(amido amine)s enhances the transfection efficiency, most
probably by promotion of the release of the genetic material
in the intracellular space by reductive cleavage of the disulfide
bonds.[23–27] In this paper we report on the synthesis and gene
delivery properties of a series of novel poly(amido amine)s that
contain both disulfide linkages in their backbone as well as dif-
ferent amounts of quaternary nicotinamide moieties in their
side chains (see Scheme 2). It was hypothesized that
presence of the positively charged, planar quaternary
nicotinamide moieties in the polymer could have
beneficial effects on the polymer–DNA interactions
not only by electrostatic interaction but also by inter-
calation with DNA, resulting in increased condensa-
tion and protective shielding of the DNA due to the
proximate intercalate binding with the polymer. Qua-
ternary nicotinamide groups were selected as pend-
ant groups in these polymers above well-known in-
tercalating groups like acridinium because of the ex-
pected biocompatibility of the natural occurring qua-
ternary nicotinamide group in NAD+ .
Results and Discussion
Monomer synthesis
The quaternized nicotinamide monomer, 1-(4-amino-
butyl)-3-carbamoylpyridinium (Nic-BuNH2), was syn-
thesized by reaction of tert-butyl-4-aminobutylcarba-
mate (BocNH-BuNH2) with the 3-carbamoyl-1-(2,4-di-
nitrophenyl)pyridinium ion 1. In this reaction the nu-
cleophilic amine group of Nic-BuNH2 adds to the 6-
position of the nicotinamide ring of 1, followed by a
ring opening–ring closure reaction with the expulsion
of the 2,4-dinitroaniline group[28] and formation of
the Boc-protected product Nic-BuNHBoc in 46%
yield. Subsequent acid-catalyzed removal of the Boc
protective group gives the desired monomer, Nic-
BuNH2 in quantitative yield (Scheme 1).
Synthesis and characterization of poly(amido
amine) homopolymers and copolymers
Poly(amido amine)s ((PAA)s) with 0, 10, 30, and 50%
of the side chains provided with quaternary nicotina-
mide moieties were synthesized by Michael addition
polymerization of bisacrylamide CBA with the appropriate ratio
of Nic-BuNH2/BocNH-BuNH2 (Scheme 2).
The polymerizations were carried out with equimolar mono-
meric ratios of primary amine and bisacrylamide. During the
polymerization a gradual increase in viscosity was observed. In
all cases gelation did not occur. To consume any unreacted ac-
rylamide groups after polymerization 15 mol% excess BocNH-
BuNH2 was added to the reaction mixture. The polymers, ob-
tained in ~30% yield, were isolated by exhaustive ultrafiltra-
tion, followed by freeze-drying. The resulting PAA homo- and
copolymers have a good solubility in water. The 1H NMR spec-
tra of these polymers were in full accordance with the expect-
ed structures, implying that the obtained composition ratio is
equal to the applied feed ratio of the different monomers
(Figure 1). No signals were observed between 5 and 7 ppm, in-
dicating that acryl groups are essentially absent (2%) and
the PAAs are end-capped with amino groups. A combination
of small angle light scattering, high angle light scattering, and
refractive index measurements showed that the weight-aver-
Scheme 1. Synthesis of monomer Nic-BuNH2. Reagents and conditions: a) MeOH, reflux,
12 h; b) TFA, MeOH, 8 h.
Scheme 2. Synthesis of poly(amido amine)s p(NicX-NHBoc), where X represents the per-
centage of side chains containing the quaternized nicotinamide moiety (X=0, 10, 30,
and 50%).
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age molecular weight (Mw) of
the PAAs ranges from 6300 to
26000 gmol1.
Acid-based deprotection of
the Boc-protected amino groups
of the side chain of the polymers
yielded polymers with various
amounts of primary amino
groups and quaternary nicotina-
mide groups in the side chains
(Scheme 3). Acetylation of the
primary amino groups further
allows the evaluation of effects
of the presence of (protonated)
primary amino groups compared
to quaternary nicotinamide
groups as well as effects of
changes in hydrophobicity[29] of
the side chain (acetylated versus
Boc-protected amino groups).
The removal of the Boc protec-
tive groups and the subsequent
acetylation of the resulting free
amino groups could be followed
by the changes of the appropriate signals in the
1H NMR spectra. The disappearance of the signal at
d=1.5 ppm after addition of TFA to the p(NicX-
NHBoc) polymers clearly shows that the Boc group
was removed from the protected amino groups. Simi-
larly, the appearance of a signal at d=2.3 ppm upon
addition of acetic anhydride to the p ACHTUNGTRENNUNG(NicX-NH2) poly-
mers shows that acetylation of the free amino
groups in the polymers has occurred.
As has been pointed out before, endosomal
escape is one of the main barriers for efficient gene
delivery. The so-called proton sponge hypothesis has
been postulated to explain endosomal disruption by
cationic polymers with ionizable amine groups, such
as B-pEI.[30] This theory assumes that in the endo-
some, basic amine groups in the polymer become
protonated when the pH drops from pH 7.4 to ap-
proximately 5, resulting in an influx of chloride ions
and water into the endosomal compartment, leading
to swelling and, eventually, osmotic lysis.[31] From our
previous studies we have observed that the buffer
capacity of the poly(amido amine)s, defined as the
percentage of amino groups that becomes protonat-
ed in the pH range 7.4 to 5.1, may be a relevant pa-
rameter in the overall transfection process.[24–26] It is
important to note that the buffer capacity as defined
for this pH range does not take into account the
amount of nitrogen groups that are already protonat-
ed at pH 7.4 or higher. Moreover, besides osmotic ef-
fects conformational changes in the polymer, due to
an increased degree of protonation of the polymer
backbone, may play a role in the endosomal escape
process. The buffer capacity of the Boc-protected
Figure 1. 1H NMR spectrum of copolymer p(Nic50-NHBoc) (D2O, 300 MHz).
Scheme 3. Deprotection and acetylation of PAAs. Reagents and conditions: a) TFA,
MeOH, 6 h, b) Ac2O, MeOH, 60 8C, 6 h.
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p(NicX-NHBoc) polymers, together with PEI as a reference, is il-
lustrated in the acid-base titration curves depicted in Figure 2.
The relatively flat slope in the pH range 5.1–7.4 indicates the
high buffer capacity (68%–75%) of the PAA polymers in this
region, which is significantly higher than that of 25k branched
PEI (17%) (see also the data in Table 1).
Obviously, the buffer capacity of the polymers with free
amino groups in the side chain is much lower than that of the
polymers with the Boc-protected amino groups, reflecting the
higher degree of protonation of the former polymers at
pH 7.4. For example, comparing the polymers containing 10%
of nicotinamide moieties, the buffer capacity decreases from
70% for p(Nic10-NHBoc) to 33% for p(Nic10-NH2). Acetylation
of the free amino groups results
in a decreased amount of pro-
tonated amino groups at pH 7.4,
similar to the Boc-protected
polymers, and therefore an in-
crease of the buffer capacity in
the pH range 7.4–5.1 is ob-
served. Polymer p(Nic10-NHAc)
shows a buffer capacity of 57%,
which is much higher than that
of p(Nic10-NH2), but lower than
that of p(Nic10-NHBoc). As
p(Nic10-NHAc) and p(Nic10-
NHBoc) have the same amount
of basic nitrogens, the difference
may be explained by the stron-
ger hydrophobic environment of
p(Nic10-NHBoc), giving rise to a
lower degree of protonation of
this polymer at pH 7.4.
Characterization of polymer/DNA complexes
A requisite for their function as a gene delivery vehicle is that
the cationic polymers are able to condense DNA into nano-
sized particles.[32,33] The particle size and zeta-potential of poly-
plexes based on the different polymers at a polymer/DNA
mass ratio 12/1 are shown in Figure 3.
Except for the Boc-protected polymers without or with only
10% nicotinamide groups (p(Nic0-NHBoc) and p(Nic10-
NHBoc)), all other polymers are able to condense DNA into
nanosized particles 200 nm. It is clear that the presence of
increasing amounts of quaternary nicotinamide moieties at the
side chain leads to a decrease of the particle size of the poly-
plexes, indicating a positive influence on the DNA condensa-
tion by these groups. The importance of the hydrophobicity of
the side groups on the condensation properties of these poly-
mers is clearly reflected in the differences in size and zeta po-
tential of the polyplexes formed from p(NicX-NHBoc) and
p(NicX-NHAc). The more hydrophobic side chains of p(NicX-
NHBoc) are expelled from the aqueous environment and
induce a higher polymer density in the interior of the polyplex
particle, thereby exposing DNA more strongly to the surface.




0 67 29 54
10 70 32 57
30 72 36 61
50 75 –[b] –[b]
[a] Buffer capacity (% change in protonation) between pH 7.4 and 5.1 in
150 mm NaCl. [b] Not determined.
Figure 3. Average particle size (solid bars) and zeta potential (connecting lines) of polyplexes of PAAs at polymer/
DNA mass ratios 12/1 (20 mm HEPES buffer, pH 7.4, 5 wt% glucose).
Figure 2. Titration curves obtained by titrating aqueous solutions (pH 2, ad-
justed with 1m HCl) of poly(amido amine) (25 mm amino nitrogen atoms) in
10 mL of 150 mm aqueous NaCl with 0.1m NaOH.
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This is reflected in the low zeta potential of polyplexes from
p(Nic0-NHBoc) and p(Nic10-NHBoc), containing the highest
amount of Boc groups. Moreover, such assembling with low
surface charge allows further growth to large particles. For
polymers p ACHTUNGTRENNUNG(NicX-NH2), the small size of the polyplexes (~90 nm
for p(Nic10-NH2) and p(Nic30-NH2)) can be attributed to the
higher net positive charge of these polymers, due to the pres-
ence of protonated primary amino groups in the side chain,
and the positive contribution of intercalation and electrostatic
interaction of the quaternary nicotinamide groups with DNA.
Influence of the quaternary nicotinamide moieties in DNA
binding and shielding
To investigate the effect of the quaternary nicotinamide moiet-
ies in the DNA binding and shielding capacity, the degree of
intercalation of ethidium bromide with accessible DNA and the
competitive displacement of DNA by heparin were measured
by fluorescence.[34] Figure 4 shows the change in ethidium bro-
mide fluorescence upon addition of heparin to polyplexes of
the different copolymers. The addition of heparin to the poly-
plexes results in an increase of the fluorescence signal of ethid-
ium bromide due to an increased accessibility of DNA for inter-
calation with the ethidium ion. From Figure 4 it is clear that
the increase of fluorescence is much lower for polyplexes
formed with polymers possessing the higher ratios of quater-
nary nicotinamide moieties, indicating that the presence of the
nicotinamide groups leads to an extra stabilization of the poly-
plexes relative to the heparin–polymer interaction. Similar re-
sults were obtained with pNic30-NH2 polyplexes, supporting
the assumption that specific interaction between the quaterna-
ry nicotinamide groups and DNA is responsible for the extra
stabilizing effect of he polyplexes.
The intercalation capability of quaternary nicotinamide
groups with DNA was clearly illustrated by the addition of the
low-molecular mass model compound Nic-BuNHBoc to a solu-
tion of ethidium bromide and
DNA (Nic-BuNHBoc/DNA 48/1
mass ratio). This resulted in a dis-
tinct decrease of the fluores-
cence signal, indicating the dis-
placement of ethidium bromide
by the quaternary nicotinamide
group of Nic-BuNHBoc (Fr=
9.9%). Subsequent addition of
heparin to the solution restored
the fluorescence of ethidium bro-
mide (Fr=13.2%) due to binding
of the positively charged Nic-
BuNHBoc to the negatively
charged heparin.
In vitro transfection efficiency
and cell viability
The transfection of polyplexes
based on these poly(amido
amine)s was studied in vitro by using COS-7 cells and plasmid
pCMV-LacZ as reporter gene, and their cell viabilities were eval-
uated by XTT assays. Figure 5 shows the transfection efficien-
cies and the cell viability of the polyplexes based on the PAA
polymers at 12/1 polymer/DNA mass ratio together with the
reference polymer Exgen 500 (linear PEI) at its optimal N/P
ratio (5/1) in the absence of serum.[35]
For all three types of PAAs, the presence of quaternary nico-
tinamide moieties has a significant influence on the transfec-
tion efficiency. The beneficial effect of these moieties is most
clearly present in the p(Nic30-NHBoc) and p(Nic30-NHAc) poly-
mers, containing 30% of quaternary nicotinamide groups, with
transfection efficiencies up to four times higher than that of
Exgen500. Moreover, polymers of this composition display no
cytotoxic effects. The low transfection efficiencies of p(Nic0-
NHBoc) and p(Nic10-NHBoc) can be attributed to their low sur-
face charge and large particle size (see Figure 3), whereas poly-
plexes of pACHTUNGTRENNUNG(NicX-NH2) show appreciable cytotoxicity, probably
Figure 4. Ethidium bromide fluorescence (relative intensity) of polyplexes
formed with p(NicX-NHBoc) before (^)and after (&) the addition of 3 eq of
heparin (respect to DNA). The polyplexes were formed at polymer/DNA ratio
48/1 (w/w).
Figure 5. Transfection efficiencies (bars) and corresponding cell viabilities (connecting lines) of polyplexes of poly(-
amido amine)s containing different percentages of quaternary nicotinamide moieties in COS-7 cells at 12/1 poly-
mer/DNA mass ratio in the absence of serum. The transfection efficiency of Exgen 500 polyplexes at their optimal
N/P ratio of 5/1 was taken as reference (set at 1.0). Cell viability was determined by XTT assay. Data are expressed
as mean values (standard deviations) of at least three experiments.
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due to the high positive charge density of these polymers with
protonated amino groups in their side chain. However, when
transfection experiments with p ACHTUNGTRENNUNG(NicX-NH2) were performed at
a much lower 3/1 polymer/DNA mass ratio to reduce excess of
positively charged polymer, cytotoxicity is essentially absent
and much higher transfection efficiencies are observed, that is,
for p(Nic30-NH2) the transfection is approximately 3.7 times
higher than that of Exgen 500 (Figure 6).
As the presence of serum more closely resembles the in vivo
environment, the influence of the presence of serum on the
transfection was also evaluated. For polyplexes with positive
surface charge it can be expected that the presence of serum
will lead to a decrease of transfection efficiency due to adsorp-
tion of serum proteins and formation of aggregates.[36] Gener-
ally, for the poly(amino amine)s used in this study a 2–3-fold
decrease in transfection was observed compared to the serum-
free medium. Similar to the serum-free medium, the polymers
containing 30% of nicotinamide groups p(Nic30-NHBoc) and
p(Nic30-NHAc) exhibit the highest transfection efficiency (still
up to 1.6 times higher than that of the reference Exgen 500,
which was always measured under standard serum-free condi-
tions). As expected, the transfection of p ACHTUNGTRENNUNG(NicX-NH2) polymers is
more strongly reduced by the presence of serum than that of
the Boc-protected and acetylated polymers, caused by the in-
teraction of the protonated amino groups with the serum pro-
teins (Figure 7).
Conclusions
A synthetic route has been developed to introduce variable
amounts of quaternary nicotinamide moieties in linear poly(a-
mido amine)s by Michael addition polymerization. These novel
polymers are able to condense DNA into nanosized particles
with average diameters 200 nm and positive surface charge.
The polymers possess high buffer capacities in the pH range
7.4–5.1, a property that may favorably contribute to endoso-
mal escape and therefore to their efficiency as gene delivery
vector. The presence of quaternary nicotinamide moieties in
the polymer leads to an increased DNA binding capacity,
which can be attributed to a combination of electrostatic and
intercalating interactions. Polyplexes from p(Nic30-NHBoc) and
p(Nic30-NHAc), having 30% of quaternary nicotinamide groups
in their side chains, show much higher transfection than the
polyplexes from similar polymers lacking the nicotinamide
group, and up to four times higher transfection is observed
compared to the reference polymer Exgen500 (linear PEI).
Moreover, these polymers display essentially no cytotoxicity,
which is an additional advantage compared to PEI. The pres-
ence of the Boc-protected amino groups in p(NicX-NHBoc) and
the free amino groups in pACHTUNGTRENNUNG(NicX-NH2) allows further modifica-
tion of these polymers for in vivo application, which will be
part of our future studies.
Experimental Section
Materials
N,N’-cystaminebisacrylamide (CBA, polysciences, USA), tert-butyl-4-
aminobutylcarbamate (BocNH-BuNH2, Aldrich), branched polyethy-
lenimine (B-pEI, Mw 25 kDa, Aldrich), linear polyethylenimine
(Exgen 500, Fermentas, Germany), and heparin (from porcine
mucosa, MW 6000–30000, Sigma) were purchased in the highest
purity and used without further purification. Ultrafiltration mem-
branes (MWCO 1000) were ordered from Millipore. The plasmid
pCMVLacZ, containing a bacterial LacZ gene preceded by a nuclear
localization signal under control of a CMV promoter, was pur-
chased from Plasmid Factory (Bielefeld, Germany).
Figure 6. Transfection efficiencies (bars) and corresponding cell viabilities
(connecting lines) of polyplexes of poly(amido amine)s p ACHTUNGTRENNUNG(NicX-NH2) contain-
ing different percentages of quaternary nicotinamide moieties in COS-7 cells
at 3/1 polymer/DNA mass ratio in the absence of serum. The transfection ef-
ficiency of Exgen 500 polyplexes at their optimal N/P ratio of 5/1 was taken
as reference (set at 1.0). Cell viability was determined by XTT assay. Data are
expressed as mean values (standard deviations) of at least three experi-
ments.
Figure 7. Transfection efficiencies in the absence (black bars) and the pres-
ence (white bars) of serum of polyplexes of poly(amido amine)s with the dif-
ferent side chains in COS-7 cells at their optimum polymer/DNA mass ratio.
The serum-free transfection efficiency of Exgen 500 polyplexes at their opti-
mal N/P ratio of 5/1 was taken as reference (set at 1.0).
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Synthesis of Nicotinamide-containing monomers
Nic-BuNHBoc, 1-(4-tert-butoxycarbonylaminobutyl)-3-carbamoylpyr-
idinium, was synthesized as its chloride salt following literature
procedures[28] (Scheme 1). In short, to a solution of 3-carbamoyl-1-
(2,4-dinitrophenyl)pyridinium chloride 1 (1 equiv) in methanol was
added tert-butyl-4-aminobutylcarbamate (BocNH-BuNH2) (3 equiv).
The mixture was refluxed for 12 h. After cooling to room tempera-
ture, Et2O was added and the solvent decantated. The residue was
washed three times with acetonitrile. The solvent was decanted to
afford Nic-BuNHBoc as a yellow solid. Yield: 46%, 1H NMR
(300 MHz, [D6]DMSO, 25 8C, TMS): d=9.61 (s, 1H, C2H), 9.23 (d, J-
ACHTUNGTRENNUNG(H,H)=6 Hz, 1H, C4H), 9.00 (d, J ACHTUNGTRENNUNG(H,H)=8 Hz, 1H, C6H), 8.76 (s, 1H,
CONH2), 8.27 (dd, JACHTUNGTRENNUNG(H,H)=6 and 8 Hz, 1H, C5H), 8.16 (s, 1H,
CONH2), 6.87 (s, 1H, NHCO), 4.67 (t, JACHTUNGTRENNUNG(H,H)=7 Hz, 2H, C7H2), 2.96
(d, J ACHTUNGTRENNUNG(H,H)=6 Hz, 2H, C10H2), 1.91 (m, 2H, C8H2), 1.42 (m, 2H, C9H2),
1.40–1.35 ppm (s, 9H, Boc); 13C NMR (75 MHz, [D6]DMSO, 25 8C):
d=163.5 (CONH2), 156.4 (NHCOO), 147.0, 145.5 and 144.2 (C2,4,6),
134.5 and 128.5 (C3,5), 78.3 (C11), 61.5 (C7), 40.1 (C10), 28.9 (Boc), 28.7




Nic-BuNH2, 1-(4-aminobutyl)-3-carbamoylpyridinium, was obtained
as its triflate salt after deprotection of Nic-BuNHBoc with TFA (3
equivalents) in MeOH. After evaporation of the solvent, the prod-
uct was obtained as a pale brown solid. Yield=99%, 1H NMR
(300 MHz, D2O, 25 8C, TMS): d=9.38 (s, 1H, C2H), 9.08 (d, J ACHTUNGTRENNUNG(H,H)=
6 Hz, 1H, C4H), 8.94 (d, JACHTUNGTRENNUNG(H,H)=8 Hz, 1H, C6H), 8.25 (dd, J ACHTUNGTRENNUNG(H,H)=6
and 8 Hz, 1H, C5H), 4.76 (t, J ACHTUNGTRENNUNG(H,H)=4 Hz, 2H, C7H2), 3.10 (d, J ACHTUNGTRENNUNG(H,H)=
7 Hz, 2H, C10H2), 2.18 (m, 2H, C8H2), 1.81 ppm (m, 2H, C9H2);
13C NMR (75 MHz, D2O, 25 8C): d=165.9 (CONH2), 146.7, 144.6 and
144.3 (C2,4,6), 134.3 and 128.7 (C3,5), 61.7 (C7), 38.8 (C10), 27.8 (C8),
23.7 ppm (C9) ; MS (FAB), m/z 194.2 ([M
+]), calc for [C10H16N3O
+]
194.2.
Synthesis of poly(amido amine)s (PAAs)
Homopolymers : PAA homopolymers can be readily synthesized by
Michael addition of the appropriate monoamine compound and
CBA in equimolar amounts.[20, 23–25] For the synthesis of the p(Nic0-
NHBoc) homopolymer (Scheme 2), 1.22 g of BocNH-BuNH2
(6.47 mmol, 1 equiv) and 1.69 g of CBA (6.47 mmol, 1 equiv) were
dissolved in a 4:1 mixture of MeOH:H2O (3.2 mL) in a brown reac-
tion flask under inert atmosphere. Polymerization was carried out
in the dark at 40 8C. The reaction mixture became homogeneous in
less than 1 h and the reaction was allowed to proceed for 5 days
yielding a viscous solution. Subsequently, 15 mol% excess BocNH-
BuNH2 (0.18 g, 0.97 mmol) was added to consume any unreacted
acrylamide groups and stirring was continued for 2 days at 40 8C.
The resulting solution was diluted with water to about 30 mL,
acidified with 4m HCl to pH~4, and then ultrafiltrated through a
ultrafiltration membrane (MWCO 1000 gmol1) for 1 day. After
freeze-drying, the p(Nic0-NHBoc) homopolymer was collected as
the HCl salt.
Copolymers : PAA copolymers with varying amounts of quaternary
nicotinamide moieties were synthesized by reaction of CBA with a
mixture of BocNH-BuNH2 and Nic-BuNH2 at various ratios (that is,
90/10, 70/30, and 50/50). In a typical experiment, the p(Nic50-
NHBoc) copolymer was synthesized by adding 0.57 g of CBA
(2.20 mmol, 1 equiv), 0.21 g of BocNH-BuNH2 (1.10 mmol,
0.5 equiv), and 0.22 g of Nic-BuNH2 (1.10 mmol, 0.5 equiv) into a
brown reaction flask with methanol as a solvent (1.1 mL) and stir-
ring the reaction mixture at 40 8C in the dark under nitrogen at-
mosphere. The reaction was allowed to proceed for 5 days, yield-
ing a viscous solution. Subsequently, 15 mol% excess of BocNH-
BuNH2 (0.06 g, 0.33 mmol) was added to consume any unreacted
acrylamide groups and stirring was continued for 2 days at 40 8C.
The resulting solution was diluted with water to about 30 mL,
acidified with 4m HCl to pH~4, and dialyzed through dialysis
membrane (MWCO 1000 gmol1) for 3 days. After freeze-drying the
copolymer was obtained as HCl salt. In a similar way, the copoly-
mers p(Nic30-NHBoc) and p(Nic10-NHBoc) were prepared after re-
action of 5 days. The composition of these polymers was estab-
lished by 1H NMR (D2O, 300 MHz).
Deprotection and acetylation of PAAs
The Boc-protecting groups of the side chain of the homopolymer
and copolymers p(NicX-NHBoc) (X=0% and 10 or 30%, respective-
ly) were removed using trifluoroacetic acid (TFA) in methanol to
obtain the pACHTUNGTRENNUNG(NicX-NH2) polymers with free terminal amino-groups.
In a typical example, 1.00 g of polymer (~2.2 mmol of monomer
unit, 1 equiv) was dissolved in 5 mL of MeOH and 0.5 mL of TFA (~
6.6 mmol, 3 equiv) was added dropwise. The reaction mixture was
stirred at room temperature for 6 h. The resulting solution was di-
luted with water to about 30 mL, acidified with 4m HCl to pH ~4,
and dialyzed through dialysis membrane (MWCO 1000 gmol1) for
1 day. After freeze-drying the copolymer was obtained as HCl salt
to avoid undesired reactions.[28]
Acetylation of the free amino-groups in the p ACHTUNGTRENNUNG(NicX-NH2) polymers
to yield the p(NicX-NHAc) polymers was performed following litera-
ture procedures.[37, 38] For example, 0.12 g of polymer pACHTUNGTRENNUNG(Nic0-NH2)
(0.34 mmol, 1 equiv) were dissolved in 5 mL of freshly distilled
methanol and 0.2 mL of acetic anhydride (1.36 mmol, 4 equiv)
were added. The reaction mixture was stirred to for 6 h at 60 8C.
The reaction was then quenched with 20 mL of water, and dialyzed
through dialysis membrane (MWCO 1000 gmol1) for 1 day. Subse-
quently, the solution was lyophilized to afford the p(Nic0-NHAc)
polymer.
Polymer characterizations
1H and 13C NMR spectra were recorded on Varian Inova spectrome-
ter operating at 300 MHz and 75 MHz, respectively. For 13C NMR
spectra, polymer samples were prepared by dissolving polymer (in
salt-free form, about 150 mg) in 0.7 mL of D2O.
Molecular weight (Mw) determination of the p(NicX-NHBoc) poly-
mers using GPC did not yield reliable results which is probably due
to the amphiphatic state of these polymers. Therefore, the Mw was
estimated from a combination of light scattering (90 and 78), re-
fractive index (RI), and viscosimetry measurements[39] using a
TDA302 system (Viscotec, Oss, The Netherlands). A water/methanol
mixture (1/4) was used as the solvent. This yielded the following
data: p(Nic50-NHBoc), Mw 19.6 ACHTUNGTRENNUNG(2.5) kD; p(Nic30-NHBoc), Mw 26.0-
ACHTUNGTRENNUNG(1.9) kD; p(Nic10-NHBoc), Mw 6.3 ACHTUNGTRENNUNG(0.4) kD; p(Nic0-NHBoc) Mw>
1 kD, could not be accurately determined. It should be noted that
the Mw values thus obtained are probably underestimated, as this
method yields for the commercial B-PEI 25 kid an Mw value of
13.1 kD.
The buffering capacity of the PAA polymers was determined by
acid-base titration. An amount equal to 2.5 mmol of amine groups
of the PAA polymer was dissolved in 5 mL of 150 mm NaCl aque-
ous solution. The pH of the polymer solution was set at 2.0 and
the solution was titrated with 0.1m NaOH solution using an auto-
matic titrator (Metrohm 702 SM Titrino). For comparison, branched
pEI (Mw=25 kDa) dissolved in 150 mm aqueous solution adjusted
to pH 2.0, was also titrated using the same method. The buffering
capacity defined as the percentage of amine groups becoming
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protonated from pH 5.1 to 7.4, was calculated from equation:
Buffer capacity (%)=100(DVNaOH·0.1mN
1mol1, wherein DVNaOH is
the volume of NaOH solution (0.1m) required to bring the pH
value of the polymer solution from 5.1 to 7.4, and N mole
(2.5 mmol) is the total moles of protonable amine groups in PAA
polymer.
Particle size and zeta-potential measurements
The surface charge and the size of polyplexes were measured at
25 8C with a Zetasizer 2000 instrument and a Zetasizer 4000, re-
spectively (Malvern Instruments Ltd. , Malvern, UK). PAA/plasmid
DNA polyplexes at a polymer/DNA mass ratio 12/1 were prepared
by adding a HEPES buffer solution (20 mm, pH 7.4, 5 wt% glucose)
of poly(amido amine)s (800 mL, 225 mgmL1) to a HEPES buffer so-
lution (20 mm, pH 7.4, 5 wt% glucose) of plasmid DNA (200 mL,
75 mgmL1), followed by vortexing for 5 s and incubating at room
temperature for 30 min. The use of HEPES glucose buffer solution
enables the parallel comparison of both zeta-potential and particle
size of different PAA polyplexes in the same samples. HEPES glu-
cose buffer solution is also used to prepare polyplex samples for
the in vitro transfection experiments. It should be noted, however,
that the zeta-potentials of polyplexes in HEPES saline buffer solu-
tion are generally lower than those measured in HEPES glucose
buffer solution, due to surface shielding effects of a higher counter
ion concentration.
Fluorescence measurements
To asses whether the quaternary nicotinamide moieties have a pos-
itive interaction with the pDNA, free DNA was detected by fluores-
cence with ethidium bromide that was added to a DNA solution
(75 mgmL1) in a 1:10 molar ratio to the DNA phosphates.[40] A so-
lution of the different polymers (800 mL, 0.9 mgmL1 in HBS) was
added to 200 mL of DNA, vortexed for 5 s, and incubated for
30 min. Similarly, a 48/1 mass ratio of Nic-BuNHBoc was added to
the solution of DNA. The fluorescence of these dispersions was
measured before and after the addition of heparin solution
(7.5 mL, 2 mgmL1).[41] The fluorescence was measured using an
Edinburgh FS900 spectrofluorometer. The excitation and emission
wavelength were 520 and 600 nm, respectively. The relative fluo-
rescence (Fr) values were determined from the equation: Fr=
(FobsFe)/ ACHTUNGTRENNUNG(F0Fe), where Fobs is the fluorescence of the polyplex dis-
persion (before or after the addition of heparin solution), Fe is the
fluorescence of ethidium bromide in the absence of DNA, and F0 is
the initial fluorescence of DNA/ethidium bromide in the absence
of polymer.
In vitro transfection and cell viability assays
Transfection experiments were performed with COS-7 cells (SV-40
transformed African Green monkey kidney cells) by using the plas-
mid pCMV-LacZ as reporter gene as reported previously.[40,41] Two
parallel transfection series, one for the determination of reporter
gene expression (b-galactosidase) and the other for the evaluation
of cell viability by XTT assay, were carried out in separate 96-well
plates (approximately 1.0O104 cells per well). Different polymer/
plasmid DNA weight ratios, ranging from 3/1 to 12/1 (w/w), were
used to prepare the polyplexes. In brief, polyplexes were prepared
by adding 200 mL of a HEPES buffer solution (20 mm, 130 mm NaCl,
pH 7.4) of poly(amido amine) with varying concentrations (from
37.5 to 150 mgmL1) to 50 mL of a HEPES buffer solution (20 mm,
130 mm NaCl, pH 7.4) of plasmid DNA (50 mgmL1), followed by
gentle shaking and incubating at room temperature for 30 min. All
transfection and toxicity assays were carried out in triplicate. In a
standard transfection experiment, the cells were incubated with
the desired amount of polyplexes (100 mL dispersion with 1 mg
plasmid DNA per well) for 1 h at 37 8C in a humidified 5% CO2-con-
taining atmosphere. Next, the polyplexes were removed. 100 mL of
fresh culture medium was added and the cells were cultured for
2 days. The transfection efficiency was determined by measuring
the activity of b-galactosidase using the ONPG assay.[42,43] Exgen
500 at 5 N/P ratio was used as a reference.[35] The number of viable
cells was measured using an XTT assay.[44] The XTT value for un-
treated cells (that is, cells not exposed to the transfection medium)
was taken as 100% cell viability.
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